Esperion Therapeutics Inc
NASDAQ:ESPR

Watchlist Manager
Esperion Therapeutics Inc Logo
Esperion Therapeutics Inc
NASDAQ:ESPR
Watchlist
Price: 1.19 USD -4.03% Market Closed
Market Cap: 235.9m USD

Wall Street
Price Targets

ESPR Price Targets Summary
Esperion Therapeutics Inc

Wall Street analysts forecast ESPR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ESPR is 5.9 USD with a low forecast of 1.52 USD and a high forecast of 16.8 USD.

Lowest
Price Target
1.52 USD
27% Upside
Average
Price Target
5.9 USD
396% Upside
Highest
Price Target
16.8 USD
1 312% Upside
Esperion Therapeutics Inc Competitors:
Price Targets
4523
Eisai Co Ltd
30% Upside
600196
Shanghai Fosun Pharmaceutical Group Co Ltd
8% Upside
600566
Hubei Jumpcan Pharmaceutical Co Ltd
22% Upside
VRCA
Verrica Pharmaceuticals Inc
406% Upside
SUPN
Supernus Pharmaceuticals Inc
18% Upside
FUM
Futura Medical PLC
158% Upside
NATCOPHARM
Natco Pharma Ltd
4% Upside

Revenue
Forecast

Revenue Estimate
Esperion Therapeutics Inc

The compound annual growth rate of Esperion Therapeutics Inc's revenue for the next 3 years is 12%.

N/A
Past Growth
12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Esperion Therapeutics Inc

The compound annual growth rate of Esperion Therapeutics Inc's operating income for the next 3 years is 11%.

N/A
Past Growth
11%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Esperion Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ESPR's stock price target?
Price Target
5.9 USD

According to Wall Street analysts, the average 1-year price target for ESPR is 5.9 USD with a low forecast of 1.52 USD and a high forecast of 16.8 USD.

What is Esperion Therapeutics Inc's Revenue forecast?
Projected CAGR
12%

The compound annual growth rate of Esperion Therapeutics Inc's revenue for the next 3 years is 12%.

What is Esperion Therapeutics Inc's Operating Income forecast?
Projected CAGR
11%

The compound annual growth rate of Esperion Therapeutics Inc's operating income for the next 3 years is 11%.

Back to Top